BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Street SE, Cretney E, Smyth MJ. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood. 2001;97:192-197. [PMID: 11133760 DOI: 10.1182/blood.v97.1.192] [Cited by in Crossref: 370] [Cited by in F6Publishing: 146] [Article Influence: 18.5] [Reference Citation Analysis]
Number Citing Articles
1 Veerasubramanian PK, Trinh A, Akhtar N, Liu WF, Downing TL. Biophysical and epigenetic regulation of cancer stemness, invasiveness and immune action. Curr Tissue Microenviron Rep 2020;1:277-300. [PMID: 33817661 DOI: 10.1007/s43152-020-00021-w] [Reference Citation Analysis]
2 Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. Interferon-gamma and cancer immunoediting. Immunol Res 2005;32:231-45. [PMID: 16106075 DOI: 10.1385/ir:32:1-3:231] [Cited by in Crossref: 96] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
3 Lu SY, Sui YF, Li ZS, Ye J, Dong HL, Qu P, Zhang XM, Wang WY, Li YS. Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma: an in vitro study. World J Gastroenterol 2004;10:53-7. [PMID: 14695768 DOI: 10.3748/wjg.v10.i1.53] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
4 Gouw LG, Jones KB, Sharma S, Randall RL. Sarcoma immunotherapy. Cancers (Basel) 2011;3:4139-50. [PMID: 24213130 DOI: 10.3390/cancers3044139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 He ZD, Zhang M, Wang YH, He Y, Wang HR, Chen BF, Tu B, Zhu SQ, Huang YZ. Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy. Acta Pharmacol Sin 2021;42:1516-23. [PMID: 33311600 DOI: 10.1038/s41401-020-00570-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Apollonio B, Ioannou N, Papazoglou D, Ramsay AG. Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy. Front Oncol 2021;11:626818. [PMID: 33842331 DOI: 10.3389/fonc.2021.626818] [Reference Citation Analysis]
7 Namjoshi P, Showalter L, Czerniecki BJ, Koski GK. T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells. Oncotarget 2019;10:6006-20. [PMID: 31666931 DOI: 10.18632/oncotarget.10298] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Robertson FC, Berzofsky JA, Terabe M. NKT cell networks in the regulation of tumor immunity. Front Immunol 2014;5:543. [PMID: 25389427 DOI: 10.3389/fimmu.2014.00543] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
9 Demaria S, Formenti SC. Role of T lymphocytes in tumor response to radiotherapy. Front Oncol 2012;2:95. [PMID: 22937524 DOI: 10.3389/fonc.2012.00095] [Cited by in Crossref: 73] [Cited by in F6Publishing: 92] [Article Influence: 8.1] [Reference Citation Analysis]
10 Aris M, Barrio MM, Mordoh J. Lessons from cancer immunoediting in cutaneous melanoma. Clin Dev Immunol 2012;2012:192719. [PMID: 22924051 DOI: 10.1155/2012/192719] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
11 Osisami M, Keller ET. Mechanisms of Metastatic Tumor Dormancy. J Clin Med 2013;2:136-50. [PMID: 26237067 DOI: 10.3390/jcm2030136] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
12 Maueröder C, Munoz LE, Chaurio RA, Herrmann M, Schett G, Berens C. Tumor immunotherapy: lessons from autoimmunity. Front Immunol 2014;5:212. [PMID: 24860574 DOI: 10.3389/fimmu.2014.00212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
13 Favreau M, Vanderkerken K, Elewaut D, Venken K, Menu E. Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma? Oncotarget 2016;7:23128-40. [PMID: 26895468 DOI: 10.18632/oncotarget.7440] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
14 Riemensberger J, Böhle A, Brandau S. IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer. Clin Exp Immunol 2002;127:20-6. [PMID: 11882028 DOI: 10.1046/j.1365-2249.2002.01734.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
15 Terabe M, Berzofsky JA. The role of NKT cells in tumor immunity. Adv Cancer Res. 2008;101:277-348. [PMID: 19055947 DOI: 10.1016/s0065-230x(08)00408-9] [Cited by in Crossref: 196] [Cited by in F6Publishing: 125] [Article Influence: 16.3] [Reference Citation Analysis]
16 Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon? World J Hepatol 2018;10:267-76. [PMID: 29527262 DOI: 10.4254/wjh.v10.i2.267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
17 Won EJ, Ju JK, Cho YN, Jin HM, Park KJ, Kim TJ, Kwon YS, Kee HJ, Kim JC, Kee SJ, Park YW. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer. Oncotarget 2016;7:76274-90. [PMID: 27517754 DOI: 10.18632/oncotarget.11187] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 19.3] [Reference Citation Analysis]
18 Enzler T, Gillessen S, Manis JP, Ferguson D, Fleming J, Alt FW, Mihm M, Dranoff G. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med 2003;197:1213-9. [PMID: 12732663 DOI: 10.1084/jem.20021258] [Cited by in Crossref: 131] [Cited by in F6Publishing: 113] [Article Influence: 7.3] [Reference Citation Analysis]
19 Fu T, Voo KS, Wang RF. Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo. J Clin Invest 2004;114:542-50. [PMID: 15314691 DOI: 10.1172/JCI22053] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
20 Liu K. Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer. World J Gastrointest Oncol. 2010;2:399-406. [PMID: 21160903 DOI: 10.4251/wjgo.v2.i11.399] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
21 Lin Z, Xu Q, Miao D, Yu F. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Front Oncol 2021;11:644416. [PMID: 33828988 DOI: 10.3389/fonc.2021.644416] [Reference Citation Analysis]
22 Chaudhry MS, Gilmour KC, House IG, Layton M, Panoskaltsis N, Sohal M, Trapani JA, Voskoboinik I. Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predisposition. Oncoimmunology 2016;5:e1179415. [PMID: 27622035 DOI: 10.1080/2162402X.2016.1179415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
23 Dong H, Tian L, Li R, Pei C, Fu Y, Dong X, Xia F, Wang C, Li W, Guo X. IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy. Oncogene. 2015;34:5363-5371. [PMID: 25619828 DOI: 10.1038/onc.2014.459] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
24 Mattiuz R, Brousse C, Ambrosini M, Cancel JC, Bessou G, Mussard J, Sanlaville A, Caux C, Bendriss-Vermare N, Valladeau-Guilemond J, Dalod M, Crozat K. Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer. Clin Transl Immunology 2021;10:e1305. [PMID: 34277006 DOI: 10.1002/cti2.1305] [Reference Citation Analysis]
25 Street SE, Trapani JA, MacGregor D, Smyth MJ. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 2002;196:129-34. [PMID: 12093877 DOI: 10.1084/jem.20020063] [Cited by in Crossref: 253] [Cited by in F6Publishing: 216] [Article Influence: 13.3] [Reference Citation Analysis]
26 Bose S, Panda AK, Mukherjee S, Sa G. Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div 2015;10:6. [PMID: 26464579 DOI: 10.1186/s13008-015-0012-z] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 10.2] [Reference Citation Analysis]
27 Witek-Janusek L, Gabram S, Mathews HL. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology 2007;32:22-35. [PMID: 17092654 DOI: 10.1016/j.psyneuen.2006.09.011] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
28 Witek Janusek L, Tell D, Albuquerque K, Mathews HL. Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer. Brain Behav Immun 2013;30 Suppl:S149-62. [PMID: 22659062 DOI: 10.1016/j.bbi.2012.05.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
29 Mojic M, Takeda K, Hayakawa Y. The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion. Int J Mol Sci 2017;19:E89. [PMID: 29283429 DOI: 10.3390/ijms19010089] [Cited by in Crossref: 109] [Cited by in F6Publishing: 94] [Article Influence: 27.3] [Reference Citation Analysis]
30 Bailur JK, Derhovanessian E, Gueckel B, Pawelec G. Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients. J Immunother Cancer 2015;3:45. [PMID: 26500775 DOI: 10.1186/s40425-015-0090-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
31 Trapani JA, Thia KY, Andrews M, Davis ID, Gedye C, Parente P, Svobodova S, Chia J, Browne K, Campbell IG. Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology. 2013;2:e24185. [PMID: 23734337 DOI: 10.4161/onci.24185] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
32 Yazdi MH, Mahdavi M, Faghfuri E, Faramarzi MA, Sepehrizadeh Z, Hassan ZM, Gholami M, Shahverdi AR. Th1 Immune Response Induction by Biogenic Selenium Nanoparticles in Mice with Breast Cancer: Preliminary Vaccine Model. Iran J Biotechnol 2015;13:1-9. [PMID: 28959284 DOI: 10.15171/ijb.1056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
33 Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol. 2011;33:321-334. [PMID: 21523560 DOI: 10.1007/s00281-011-0270-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
34 Bi J, Tian Z. NK Cell Dysfunction and Checkpoint Immunotherapy. Front Immunol 2019;10:1999. [PMID: 31552017 DOI: 10.3389/fimmu.2019.01999] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
35 Manjili MH. Revisiting cancer immunoediting by understanding cancer immune complexity. J Pathol 2011;224:5-9. [PMID: 21480229 DOI: 10.1002/path.2865] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
36 Antoni MH, Lechner S, Diaz A, Vargas S, Holley H, Phillips K, McGregor B, Carver CS, Blomberg B. Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun 2009;23:580-91. [PMID: 18835434 DOI: 10.1016/j.bbi.2008.09.005] [Cited by in Crossref: 134] [Cited by in F6Publishing: 102] [Article Influence: 10.3] [Reference Citation Analysis]
37 Castro MG, Candolfi M, Wilson TJ, Calinescu A, Paran C, Kamran N, Koschmann C, Moreno-Ayala MA, Assi H, Lowenstein PR. Adenoviral vector-mediated gene therapy for gliomas: coming of age. Expert Opin Biol Ther. 2014;14:1241-1257. [PMID: 24773178 DOI: 10.1517/14712598.2014.91530] [Reference Citation Analysis]
38 Quezada SA, Peggs KS, Simpson TR, Allison JP. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol Rev 2011;241:104-18. [PMID: 21488893 DOI: 10.1111/j.1600-065X.2011.01007.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 92] [Article Influence: 16.5] [Reference Citation Analysis]
39 Lei X, Liu C, Azadzoi K, Li C, Lu F, Xiang A, Sun J, Guo Y, Zhao Q, Yan Z, Yang J. A novel IgM-H-ficolin complement pathway to attack allogenic cancer cells in vitro. Sci Rep 2015;5:7824. [PMID: 25592840 DOI: 10.1038/srep07824] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
40 Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001;193:661-70. [PMID: 11257133 DOI: 10.1084/jem.193.6.661] [Cited by in Crossref: 360] [Cited by in F6Publishing: 319] [Article Influence: 18.0] [Reference Citation Analysis]
41 Garcia PV, Seiva FR, Carniato AP, de Mello Júnior W, Duran N, Macedo AM, de Oliveira AG, Romih R, Nunes Ida S, Nunes Oda S, Fávaro WJ. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer 2016;16:422. [PMID: 27389279 DOI: 10.1186/s12885-016-2474-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
42 Dulphy N, Chrétien AS, Khaznadar Z, Fauriat C, Nanbakhsh A, Caignard A, Chouaib S, Olive D, Toubert A. Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells. Front Immunol 2016;7:94. [PMID: 27014273 DOI: 10.3389/fimmu.2016.00094] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
43 Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. Front Immunol 2018;9:847. [PMID: 29780381 DOI: 10.3389/fimmu.2018.00847] [Cited by in Crossref: 277] [Cited by in F6Publishing: 238] [Article Influence: 92.3] [Reference Citation Analysis]
44 Coleman IM, Kiefer JA, Brown LG, Pitts TE, Nelson PS, Brubaker KD, Vessella RL, Corey E. Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes. Neoplasia 2006;8:862-78. [PMID: 17032503 DOI: 10.1593/neo.06328] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
45 Coleman DJ, Garcia G, Hyter S, Jang HS, Chagani S, Liang X, Larue L, Ganguli-Indra G, Indra AK. Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation. PLoS Genet 2014;10:e1004321. [PMID: 24810760 DOI: 10.1371/journal.pgen.1004321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
46 Ichim CV. Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy. J Transl Med 2005;3:8. [PMID: 15698481 DOI: 10.1186/1479-5876-3-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
47 Bergman MP, D’Elios MM. Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol. 2010;2010:104918. [PMID: 20617132 DOI: 10.1155/2010/104918] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
48 Castro MG, Candolfi M, Wilson TJ, Calinescu A, Paran C, Kamran N, Koschmann C, Moreno-Ayala MA, Assi H, Lowenstein PR. Adenoviral vector-mediated gene therapy for gliomas: coming of age. Expert Opin Biol Ther 2014;14:1241-57. [PMID: 24773178 DOI: 10.1517/14712598.2014.915307] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
49 Chew V, Toh HC, Abastado JP. Immune microenvironment in tumor progression: characteristics and challenges for therapy. J Oncol 2012;2012:608406. [PMID: 22927846 DOI: 10.1155/2012/608406] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 8.1] [Reference Citation Analysis]
50 Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest. 2007;117:1137-1146. [PMID: 17476343 DOI: 10.1172/jci31405] [Cited by in Crossref: 835] [Cited by in F6Publishing: 406] [Article Influence: 59.6] [Reference Citation Analysis]
51 Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med. 2003;198:433-442. [PMID: 12900519 DOI: 10.1084/jem.20030584] [Cited by in Crossref: 269] [Cited by in F6Publishing: 233] [Article Influence: 14.9] [Reference Citation Analysis]
52 Gérard C, Baudson N, Ory T, Louahed J. Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses. PLoS One 2014;9:e94883. [PMID: 24830315 DOI: 10.1371/journal.pone.0094883] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
53 Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun 2008;22:969-81. [PMID: 18359186 DOI: 10.1016/j.bbi.2008.01.012] [Cited by in Crossref: 269] [Cited by in F6Publishing: 219] [Article Influence: 20.7] [Reference Citation Analysis]
54 Finn OJ. A Believer's Overview of Cancer Immunosurveillance and Immunotherapy. J Immunol 2018;200:385-91. [PMID: 29311379 DOI: 10.4049/jimmunol.1701302] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 17.3] [Reference Citation Analysis]
55 Neumann T, Canli Ö, Greten FR. Canonical NF-κB signaling in myeloid cells promotes lung metastasis in a mouse breast cancer model. Oncotarget 2018;9:16775-91. [PMID: 29682184 DOI: 10.18632/oncotarget.24697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Ruffell B, DeNardo DG, Affara NI, Coussens LM. Lymphocytes in cancer development: polarization towards pro-tumor immunity. Cytokine Growth Factor Rev 2010;21:3-10. [PMID: 20005150 DOI: 10.1016/j.cytogfr.2009.11.002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 132] [Article Influence: 11.8] [Reference Citation Analysis]
57 Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ. Prospects for NK Cell Therapy of Sarcoma. Cancers (Basel) 2020;12:E3719. [PMID: 33322371 DOI: 10.3390/cancers12123719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Lee HR, Son CH, Koh EK, Bae JH, Kang CD, Yang K, Park YS. Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody. Sci Rep 2017;7:11075. [PMID: 28894091 DOI: 10.1038/s41598-017-09259-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
59 O'Sullivan T, Saddawi-Konefka R, Vermi W, Koebel CM, Arthur C, White JM, Uppaluri R, Andrews DM, Ngiow SF, Teng MW, Smyth MJ, Schreiber RD, Bui JD. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med 2012;209:1869-82. [PMID: 22927549 DOI: 10.1084/jem.20112738] [Cited by in Crossref: 197] [Cited by in F6Publishing: 174] [Article Influence: 21.9] [Reference Citation Analysis]
60 Nishioka Y, Masuda S, Tomaru U, Ishizu A. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides. Front Immunol 2018;9:548. [PMID: 29599785 DOI: 10.3389/fimmu.2018.00548] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
61 Barbarin A, Cayssials E, Jacomet F, Nunez NG, Basbous S, Lefèvre L, Abdallah M, Piccirilli N, Morin B, Lavoue V, Catros V, Piaggio E, Herbelin A, Gombert JM. Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases. Front Immunol 2017;8:316. [PMID: 28396661 DOI: 10.3389/fimmu.2017.00316] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
62 Shimaoka H, Takeno S, Maki K, Sasaki T, Hasegawa S, Yamashita Y. A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer. Oncol Lett 2017;14:3019-27. [PMID: 28928840 DOI: 10.3892/ol.2017.6473] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
63 Mathews HL, Konley T, Kosik KL, Krukowski K, Eddy J, Albuquerque K, Janusek LW. Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress. Brain Behav Immun 2011;25:830-9. [PMID: 21146603 DOI: 10.1016/j.bbi.2010.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
64 Ng SS, De Labastida Rivera F, Yan J, Corvino D, Das I, Zhang P, Kuns R, Chauhan SB, Hou J, Li XY, Frame TCM, McEnroe BA, Moore E, Na J, Engel JA, Soon MSF, Singh B, Kueh AJ, Herold MJ, Montes de Oca M, Singh SS, Bunn PT, Aguilera AR, Casey M, Braun M, Ghazanfari N, Wani S, Wang Y, Amante FH, Edwards CL, Haque A, Dougall WC, Singh OP, Baxter AG, Teng MWL, Loukas A, Daly NL, Cloonan N, Degli-Esposti MA, Uzonna J, Heath WR, Bald T, Tey SK, Nakamura K, Hill GR, Kumar R, Sundar S, Smyth MJ, Engwerda CR. The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation. Nat Immunol 2020;21:1205-18. [PMID: 32839608 DOI: 10.1038/s41590-020-0758-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
65 Langers I, Renoux VM, Thiry M, Delvenne P, Jacobs N. Natural killer cells: role in local tumor growth and metastasis. Biologics. 2012;6:73-82. [PMID: 22532775 DOI: 10.2147/btt.s23976] [Cited by in Crossref: 16] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
66 Schreiber K, Karrison TG, Wolf SP, Kiyotani K, Steiner M, Littmann ER, Pamer EG, Kammertoens T, Schreiber H, Leisegang M. Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors. Cancer Immunol Res 2020;8:192-202. [PMID: 31831634 DOI: 10.1158/2326-6066.CIR-19-0567] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 Paul S, Lal G. The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. Front Immunol 2017;8:1124. [PMID: 28955340 DOI: 10.3389/fimmu.2017.01124] [Cited by in Crossref: 158] [Cited by in F6Publishing: 138] [Article Influence: 39.5] [Reference Citation Analysis]
68 Gibellini L, De Biasi S, Porta C, Lo Tartaro D, Depenni R, Pellacani G, Sabbatini R, Cossarizza A. Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors. Front Immunol 2020;11:490. [PMID: 32265933 DOI: 10.3389/fimmu.2020.00490] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
69 Kriegsman BA, Vangala P, Chen BJ, Meraner P, Brass AL, Garber M, Rock KL. Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression. J Immunol 2019;203:1999-2010. [PMID: 31471524 DOI: 10.4049/jimmunol.1900475] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
70 Hastie C, Masters JR, Moss SE, Naaby-Hansen S. Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells. J Biol Chem 2008;283:12595-603. [PMID: 18211896 DOI: 10.1074/jbc.M800189200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
71 Werneck MB, Lugo-Villarino G, Hwang ES, Cantor H, Glimcher LH. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J Immunol 2008;180:8004-10. [PMID: 18523263 DOI: 10.4049/jimmunol.180.12.8004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
72 Zolkind P, Dunn GP, Lin T, Griffith M, Griffith OL, Uppaluri R. Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma. Oral Oncol 2017;71:169-76. [PMID: 27751760 DOI: 10.1016/j.oraloncology.2016.09.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
73 Hosseinzadeh F, Ai J, Ebrahimi-Barough S, Seyhoun I, Hajifathali A, Muhammadnejad S, Hosseinzadeh F, Shadnoush M, Dabiri Oskouei F, Verdi J. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2019;20:3797-803. [PMID: 31870124 DOI: 10.31557/APJCP.2019.20.12.3797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Souza-Fonseca-Guimaraes F, Young A, Mittal D, Martinet L, Bruedigam C, Takeda K, Andoniou CE, Degli-Esposti MA, Hill GR, Smyth MJ. NK cells require IL-28R for optimal in vivo activity. Proc Natl Acad Sci U S A 2015;112:E2376-84. [PMID: 25901316 DOI: 10.1073/pnas.1424241112] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 10.3] [Reference Citation Analysis]
75 Albuquerque K, Tell D, Lobo P, Millbrandt L, Mathews HL, Janusek LW. Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer 2012;12:251. [PMID: 22708709 DOI: 10.1186/1471-2407-12-251] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
76 Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N, Jonjic S, Lukic ML. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clin Exp Metastasis 2011;28:451-62. [PMID: 21442355 DOI: 10.1007/s10585-011-9383-y] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
77 Tu G, Peng W, Cai Q, Zhao Z, Peng X, He B, Zhang P, Shi S, Tao Y, Wang X. Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma. PeerJ 2021;9:e11687. [PMID: 34277151 DOI: 10.7717/peerj.11687] [Reference Citation Analysis]
78 Smyth MJ, Wallace ME, Nutt SL, Yagita H, Godfrey DI, Hayakawa Y. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J Exp Med 2005;201:1973-85. [PMID: 15967825 DOI: 10.1084/jem.20042280] [Cited by in Crossref: 130] [Cited by in F6Publishing: 119] [Article Influence: 8.1] [Reference Citation Analysis]
79 Crosby LM, Moore TM, George M, Yoon LW, Easton MJ, Ni H, Morgan KT, DeAngelo AB. Transformation of SV40-immortalized human uroepithelial cells by 3-methylcholanthrene increases IFN- and Large T Antigen-induced transcripts. Cancer Cell Int 2010;10:4. [PMID: 20178601 DOI: 10.1186/1475-2867-10-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
80 Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121:1-14. [PMID: 17386080 DOI: 10.1111/j.1365-2567.2007.02587] [Reference Citation Analysis]
81 Schuijs MJ, Png S, Richard AC, Tsyben A, Hamm G, Stockis J, Garcia C, Pinaud S, Nicholls A, Ros XR, Su J, Eldridge MD, Riedel A, Serrao EM, Rodewald HR, Mack M, Shields JD, Cohen ES, McKenzie ANJ, Goodwin RJA, Brindle KM, Marioni JC, Halim TYF. ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung. Nat Immunol 2020;21:998-1009. [PMID: 32747815 DOI: 10.1038/s41590-020-0745-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 22.0] [Reference Citation Analysis]
82 Gonzalez H, Robles I, Werb Z. Innate and acquired immune surveillance in the postdissemination phase of metastasis. FEBS J 2018;285:654-64. [PMID: 29131550 DOI: 10.1111/febs.14325] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
83 Arjona A, Sarkar DK. Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells. Neurochem Res 2008;33:708-18. [PMID: 17965936 DOI: 10.1007/s11064-007-9501-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
84 Thibaut R, Bost P, Milo I, Cazaux M, Lemaître F, Garcia Z, Amit I, Breart B, Cornuot C, Schwikowski B, Bousso P. Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment. Nat Cancer 2020;1:302-14. [PMID: 32803171 DOI: 10.1038/s43018-020-0038-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 32.0] [Reference Citation Analysis]
85 Shembrey C, Huntington ND, Hollande F. Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response. Cancers (Basel) 2019;11:E1217. [PMID: 31438563 DOI: 10.3390/cancers11091217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
86 Wang Y, Lu J, Jiang B, Guo J. The roles of curcumin in regulating the tumor immunosuppressive microenvironment. Oncol Lett 2020;19:3059-70. [PMID: 32256807 DOI: 10.3892/ol.2020.11437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
87 Tang L, Wang K. Chronic Inflammation in Skin Malignancies. J Mol Signal 2016;11:2. [PMID: 31051015 DOI: 10.5334/1750-2187-11-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
88 Logan RW, Zhang C, Murugan S, O'Connell S, Levitt D, Rosenwasser AM, Sarkar DK. Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. J Immunol 2012;188:2583-91. [PMID: 22308312 DOI: 10.4049/jimmunol.1102715] [Cited by in Crossref: 93] [Cited by in F6Publishing: 75] [Article Influence: 10.3] [Reference Citation Analysis]
89 Davis ZB, Felices M, Verneris MR, Miller JS. Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer. Cancer J 2015;21:486-91. [PMID: 26588681 DOI: 10.1097/PPO.0000000000000156] [Cited by in Crossref: 64] [Cited by in F6Publishing: 37] [Article Influence: 12.8] [Reference Citation Analysis]
90 Bhat H, Zaun G, Hamdan TA, Lang J, Adomati T, Schmitz R, Friedrich SK, Bergerhausen M, Cham LB, Li F, Ali M, Zhou F, Khairnar V, Duhan V, Brandenburg T, Machlah YM, Schiller M, Berry A, Xu H, Vollmer J, Häussinger D, Thier B, Pandyra AA, Schadendorf D, Paschen A, Schuler M, Lang PA, Lang KS. Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression. Front Immunol 2020;11:1849. [PMID: 32973762 DOI: 10.3389/fimmu.2020.01849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Xue L, Pestka JJ, Li M, Firestone GL, Bjeldanes LF. 3,3'-Diindolylmethane stimulates murine immune function in vitro and in vivo. J Nutr Biochem 2008;19:336-44. [PMID: 17707631 DOI: 10.1016/j.jnutbio.2007.05.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
92 Cheng M, Chen Y, Xiao W, Sun R, Tian Z. NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol. 2013;10:230-252. [PMID: 23604045 DOI: 10.1038/cmi.2013.10] [Cited by in Crossref: 372] [Cited by in F6Publishing: 347] [Article Influence: 46.5] [Reference Citation Analysis]
93 Ward JP, Gubin MM, Schreiber RD. The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer. Adv Immunol 2016;130:25-74. [PMID: 26922999 DOI: 10.1016/bs.ai.2016.01.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 20.6] [Reference Citation Analysis]
94 Uchida T, Nakashima H, Ito S, Ishikiriyama T, Nakashima M, Seki S, Kumagai H, Oshima N. Activated natural killer T cells in mice induce acute kidney injury with hematuria through possibly common mechanisms shared by human CD56+ T cells. Am J Physiol Renal Physiol 2018;315:F618-27. [PMID: 29993279 DOI: 10.1152/ajprenal.00160.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
95 Li Q, Zhang XQ, Nie L, Chen GS, Li H, Zhang F, Zhang LY, Hong L, Wang SF, Wang H. Expression of interferon-gamma in human adrenal gland and kidney tumours. Br J Cancer 2007;97:420-5. [PMID: 17622250 DOI: 10.1038/sj.bjc.6603870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
96 Voskoboinik I, Thia MC, De Bono A, Browne K, Cretney E, Jackson JT, Darcy PK, Jane SM, Smyth MJ, Trapani JA. The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J Exp Med 2004;200:811-6. [PMID: 15365097 DOI: 10.1084/jem.20040776] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
97 Alfarra H, Weir J, Grieve S, Reiman T. Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy. Front Immunol 2020;11:575609. [PMID: 33304346 DOI: 10.3389/fimmu.2020.575609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
98 Tseng PC, Chen CL, Shan YS, Lin CF. An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells. Oncotarget 2016;7:15150-60. [PMID: 26934444 DOI: 10.18632/oncotarget.7750] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
99 Stoiber D, Kovacic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, Artwohl M, Kleine OC, Muller M, Baumgartner-Parzer S, Ghysdael J, Freissmuth M, Sexl V. TYK2 is a key regulator of the surveillance of B lymphoid tumors. J Clin Invest 2004;114:1650-8. [PMID: 15578097 DOI: 10.1172/JCI22315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 25] [Article Influence: 0.2] [Reference Citation Analysis]
100 Desbois M, Rusakiewicz S, Locher C, Zitvogel L, Chaput N. Natural killer cells in non-hematopoietic malignancies. Front Immunol 2012;3:395. [PMID: 23269924 DOI: 10.3389/fimmu.2012.00395] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
101 Abou El Hassan M, Huang K, Eswara MB, Zhao M, Song L, Yu T, Liu Y, Liu JC, McCurdy S, Ma A, Wither J, Jin J, Zacksenhaus E, Wrana JL, Bremner R. Cancer Cells Hijack PRC2 to Modify Multiple Cytokine Pathways. PLoS One 2015;10:e0126466. [PMID: 26030458 DOI: 10.1371/journal.pone.0126466] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
102 He W, Hao J, Dong S, Gao Y, Tao J, Chi H, Flavell R, O'Brien RL, Born WK, Craft J, Han J, Wang P, Zhao L, Wu J, Yin Z. Naturally activated V gamma 4 gamma delta T cells play a protective role in tumor immunity through expression of eomesodermin. J Immunol. 2010;185:126-133. [PMID: 20525896 DOI: 10.4049/jimmunol.0903767] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
103 Misra P, Singh S. Role of cytokines in combinatorial immunotherapeutics of non-small cell lung cancer through systems perspective. Cancer Med 2019;8:1976-95. [PMID: 30997737 DOI: 10.1002/cam4.2112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
104 Hasapis S, Caraballo I, Lee CL. Transplantation of Unirradiated Bone Marrow Cells after Total-Body Irradiation Prevents the Development of Thymic Lymphoma in Mice through Niche Competition. Radiat Res 2021;195:301-6. [PMID: 33347573 DOI: 10.1667/RADE-20-00221.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Grimmig T, Moench R, Kreckel J, Haack S, Rueckert F, Rehder R, Tripathi S, Ribas C, Chandraker A, Germer CT, Gasser M, Waaga-Gasser AM. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer. Int J Mol Sci 2016;17:E2060. [PMID: 27941651 DOI: 10.3390/ijms17122060] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
106 Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105:256-265. [PMID: 23291374 DOI: 10.1093/jnci/djs629] [Cited by in Crossref: 595] [Cited by in F6Publishing: 550] [Article Influence: 74.4] [Reference Citation Analysis]
107 Hayakawa Y, Rovero S, Forni G, Smyth MJ. Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis. Proc Natl Acad Sci U S A 2003;100:9464-9. [PMID: 12867593 DOI: 10.1073/pnas.1630663100] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 6.3] [Reference Citation Analysis]
108 Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121:1-14. [PMID: 17386080 DOI: 10.1111/j.1365-2567.2007.02587.x] [Cited by in Crossref: 593] [Cited by in F6Publishing: 516] [Article Influence: 42.4] [Reference Citation Analysis]
109 Neeley YC, McDonagh KT, Overwijk WW, Restifo NP, Sanda MG. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC. Prostate 2002;53:183-91. [PMID: 12386918 DOI: 10.1002/pros.10136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
110 Ciążyńska M, Olejniczak-Staruch I, Sobolewska-Sztychny D, Narbutt J, Skibińska M, Lesiak A. Ultraviolet Radiation and Chronic Inflammation-Molecules and Mechanisms Involved in Skin Carcinogenesis: A Narrative Review. Life (Basel) 2021;11:326. [PMID: 33917793 DOI: 10.3390/life11040326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Arrieta VA, Cacho-Díaz B, Zhao J, Rabadan R, Chen L, Sonabend AM. The possibility of cancer immune editing in gliomas. A critical review. Oncoimmunology 2018;7:e1445458. [PMID: 29900059 DOI: 10.1080/2162402X.2018.1445458] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
112 Kyei SK, Ogbomo H, Li S, Timm-McCann M, Xiang RF, Huston SM, Ganguly A, Colarusso P, Gill MJ, Mody CH. Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients. mBio 2016;7:e00878-16. [PMID: 27555306 DOI: 10.1128/mBio.00878-16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
113 Zolkind P, Uppaluri R. Checkpoint immunotherapy in head and neck cancers. Cancer Metastasis Rev 2017;36:475-89. [PMID: 28836124 DOI: 10.1007/s10555-017-9694-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
114 Teng MW, Andrews DM, McLaughlin N, von Scheidt B, Ngiow SF, Möller A, Hill GR, Iwakura Y, Oft M, Smyth MJ. IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc Natl Acad Sci U S A 2010;107:8328-33. [PMID: 20404142 DOI: 10.1073/pnas.1003251107] [Cited by in Crossref: 91] [Cited by in F6Publishing: 73] [Article Influence: 8.3] [Reference Citation Analysis]
115 Norrie IC, Ohlsson E, Nielsen O, Hasemann MS, Porse BT. C/EBPα is dispensable for the ontogeny of PD-1+ CD4+ memory T cells but restricts their expansion in an age-dependent manner. PLoS One 2014;9:e84728. [PMID: 24404186 DOI: 10.1371/journal.pone.0084728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
116 Street SE, Hayakawa Y, Zhan Y, Lew AM, MacGregor D, Jamieson AM, Diefenbach A, Yagita H, Godfrey DI, Smyth MJ. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J Exp Med 2004;199:879-84. [PMID: 15007091 DOI: 10.1084/jem.20031981] [Cited by in Crossref: 156] [Cited by in F6Publishing: 140] [Article Influence: 9.2] [Reference Citation Analysis]
117 Barcellos-Hoff MH, Mao JH. HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis. Front Oncol 2016;6:57. [PMID: 27014632 DOI: 10.3389/fonc.2016.00057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
118 Long A, Dominguez D, Qin L, Chen S, Fan J, Zhang M, Fang D, Zhang Y, Kuzel TM, Zhang B. Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression. J Immunol 2018;201:3456-64. [PMID: 30373846 DOI: 10.4049/jimmunol.1800173] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
119 Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 2013;32:1971-7. [PMID: 22751116 DOI: 10.1038/onc.2012.206] [Cited by in Crossref: 117] [Cited by in F6Publishing: 108] [Article Influence: 13.0] [Reference Citation Analysis]
120 Mian MF, Lauzon NM, Andrews DW, Lichty BD, Ashkar AA. FimH can directly activate human and murine natural killer cells via TLR4. Mol Ther 2010;18:1379-88. [PMID: 20442710 DOI: 10.1038/mt.2010.75] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
121 Alshaker HA, Matalka KZ. IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. Cancer Cell Int 2011;11:33. [PMID: 21943203 DOI: 10.1186/1475-2867-11-33] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
122 Wischhusen J, Melero I, Fridman WH. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.Front Immunol. 2020;11:951. [PMID: 32508832 DOI: 10.3389/fimmu.2020.00951] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 30.0] [Reference Citation Analysis]
123 Sanz-Ortega L, Rojas JM, Portilla Y, Pérez-Yagüe S, Barber DF. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol 2019;10:2073. [PMID: 31543880 DOI: 10.3389/fimmu.2019.02073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
124 de Aquino MT, Malhotra A, Mishra MK, Shanker A. Challenges and future perspectives of T cell immunotherapy in cancer. Immunol Lett 2015;166:117-33. [PMID: 26096822 DOI: 10.1016/j.imlet.2015.05.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
125 Curtale G. MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages. Cells 2018;7:E12. [PMID: 29419779 DOI: 10.3390/cells7020012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
126 Miyazato K, Tahara H, Hayakawa Y. Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells. Cancer Sci 2020;111:2770-8. [PMID: 32573072 DOI: 10.1111/cas.14538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
127 Krukowski K, Eddy J, Kosik KL, Konley T, Janusek LW, Mathews HL. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun 2011;25:239-49. [PMID: 20656012 DOI: 10.1016/j.bbi.2010.07.244] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
128 Sayem MA, Tomita Y, Yuno A, Hirayama M, Irie A, Tsukamoto H, Senju S, Yuba E, Yoshikawa T, Kono K. Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response. Oncoimmunology. 2015;5:e1062209. [PMID: 26942076 DOI: 10.1080/2162402x.2015.1062209] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
129 Nguyen AH, Berim IG, Agrawal DK. Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol 2014;10:1711-30. [PMID: 25351434 DOI: 10.1586/1744666X.2014.975692] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
130 Juszczynski P, Kutok JL, Li C, Mitra J, Aguiar RC, Shipp MA. BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate. Mol Cell Biol 2006;26:5348-59. [PMID: 16809771 DOI: 10.1128/MCB.02351-05] [Cited by in Crossref: 77] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
131 Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C. Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS 2013;27:2933-42. [PMID: 23921614 DOI: 10.1097/01.aids.0000433236.55937.cb] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
132 Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, Smyth MJ. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci U S A. 2008;105:652-656. [PMID: 18178624 DOI: 10.1073/pnas.0708594105] [Cited by in Crossref: 216] [Cited by in F6Publishing: 191] [Article Influence: 16.6] [Reference Citation Analysis]
133 Kalish SV, Lyamina SV, Usanova EA, Manukhina EB, Larionov NP, Malyshev IY. Macrophages Reprogrammed In Vitro Towards the M1 Phenotype and Activated with LPS Extend Lifespan of Mice with Ehrlich Ascites Carcinoma. Med Sci Monit Basic Res 2015;21:226-34. [PMID: 26471744 DOI: 10.12659/msmbr.895563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
134 Zeng J, Harris TJ, Lim M, Drake CG, Tran PT. Immune modulation and stereotactic radiation: improving local and abscopal responses. Biomed Res Int 2013;2013:658126. [PMID: 24324970 DOI: 10.1155/2013/658126] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
135 Guillerey C, Ferrari de Andrade L, Vuckovic S, Miles K, Ngiow SF, Yong MC, Teng MW, Colonna M, Ritchie DS, Chesi M, Bergsagel PL, Hill GR, Smyth MJ, Martinet L. Immunosurveillance and therapy of multiple myeloma are CD226 dependent. J Clin Invest 2015;125:2077-89. [PMID: 25893601 DOI: 10.1172/JCI77181] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
136 Tsuruta M, Ueda S, Yew PY, Fukuda I, Yoshimura S, Kishi H, Hamana H, Hirayama M, Yatsuda J, Irie A, Senju S, Yuba E, Kamba T, Eto M, Nakayama H, Nishimura Y. Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro. Oncoimmunology 2018;7:e1415687. [PMID: 29632734 DOI: 10.1080/2162402X.2017.1415687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
137 Nishikawa H, Kato T, Tawara I, Takemitsu T, Saito K, Wang L, Ikarashi Y, Wakasugi H, Nakayama T, Taniguchi M. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci USA. 2005;102:9253-9257. [PMID: 15961541 DOI: 10.1073/pnas.0503852102] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 5.3] [Reference Citation Analysis]
138 Khodarev NN, Roach P, Pitroda SP, Golden DW, Bhayani M, Shao MY, Darga TE, Beveridge MG, Sood RF, Sutton HG, Beckett MA, Mauceri HJ, Posner MC, Weichselbaum RR. STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS One 2009;4:e5821. [PMID: 19503789 DOI: 10.1371/journal.pone.0005821] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
139 Kang HB, Ahn KS, Oh SR, Kim JW. Genkwadaphnin induces IFN-γ via PKD1/NF-κB/STAT1 dependent pathway in NK-92 cells. PLoS One 2014;9:e115146. [PMID: 25517939 DOI: 10.1371/journal.pone.0115146] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
140 Bolitho P, Street SE, Westwood JA, Edelmann W, Macgregor D, Waring P, Murray WK, Godfrey DI, Trapani JA, Johnstone RW, Smyth MJ. Perforin-mediated suppression of B-cell lymphoma. Proc Natl Acad Sci U S A 2009;106:2723-8. [PMID: 19196996 DOI: 10.1073/pnas.0809008106] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
141 Neelam S, Mellon J, Wilkerson A, Niederkorn JY. Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity. Melanoma Res 2019;29:401-12. [PMID: 30932943 DOI: 10.1097/CMR.0000000000000614] [Reference Citation Analysis]
142 Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 2009;9:568-80. [PMID: 19629084 DOI: 10.1038/nri2604] [Cited by in Crossref: 252] [Cited by in F6Publishing: 231] [Article Influence: 21.0] [Reference Citation Analysis]
143 Takeda K, Okumura K. CAM and NK Cells. Evid Based Complement Alternat Med 2004;1:17-27. [PMID: 15257322 DOI: 10.1093/ecam/neh014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
144 Stoiber D, Kovacic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, Artwohl M, Kleine OC, Muller M. TYK2 is a key regulator of the surveillance of B lymphoid tumors. J Clin Invest. 2004;114:1650-1658. [PMID: 15578097 DOI: 10.1172/jci200422315] [Cited by in Crossref: 45] [Article Influence: 2.8] [Reference Citation Analysis]
145 Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, Kalinski P, Kaufman HL, Kiessling R, Kirkwood J, Knuth A, Liblau R, Lotze MT, Lugli E, Marincola F, Melero I, Melief CJ, Mempel TR, Mittendorf EA, Odun K, Overwijk WW, Palucka AK, Parmiani G, Ribas A, Romero P, Schreiber RD, Schuler G, Srivastava PK, Tartour E, Valmori D, van der Burg SH, van der Bruggen P, van den Eynde BJ, Wang E, Zou W, Whiteside TL, Speiser DE, Pardoll DM, Restifo NP, Anderson AC. Consensus nomenclature for CD8+ T cell phenotypes in cancer. Oncoimmunology 2015;4:e998538. [PMID: 26137416 DOI: 10.1080/2162402X.2014.998538] [Cited by in Crossref: 90] [Cited by in F6Publishing: 53] [Article Influence: 15.0] [Reference Citation Analysis]
146 Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 2011;208:1989-2003. [PMID: 21930769 DOI: 10.1084/jem.20101158] [Cited by in Crossref: 585] [Cited by in F6Publishing: 539] [Article Influence: 58.5] [Reference Citation Analysis]